Artisan Partners
OCUL icon

Artisan Partners’s Ocular Therapeutix OCUL Stock Holding History

Artisan Partners’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-902,931
Closed -$7.65M – 366
2026
Q1 		$7.65M Sell
902,931
-160,440
-15% -$1.53M 0.01% 305
2025
Q4 		$12.9M Sell
1,063,371
-13,011
-1% -$158K 0.02% 308
2025
Q3 		$12.6M Buy
1,076,382
+10,413
+1% +$125K 0.02% 303
2025
Q2 		$9.89M Sell
1,065,969
-89,107
-8% -$697K 0.01% 314
2025
Q1 		$8.47M Sell
1,155,076
-179,626
-13% -$1.38M 0.01% 310
2024
Q4 		$11.4M Buy
1,334,702
+278,610
+26% +$2.72M 0.02% 318
2024
Q3 		$9.19M Buy
+1,056,092
New +$8.7M 0.01% 303

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners's OCUL Position: Q2 2026 in Review

Artisan Partners sold out of Ocular Therapeutix (OCUL) in Q2 2026, closing a stake of 902,931 shares — an estimated $7.65M sold.

Artisan Partners first reported a position in OCUL in Q3 2024 and held it in 7 quarters. The position peaked at $12.9M in Q4 2025. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Artisan Partners reported no remaining Ocular Therapeutix position as of Q2 2026 after selling out during the quarter.
  • Artisan Partners sold 902,931 Ocular Therapeutix shares in Q2 2026, an estimated $7.65M.
  • Artisan Partners first reported a position in Ocular Therapeutix in Q3 2024 and held it in 7 quarters.
  • Artisan Partners's Ocular Therapeutix position peaked at $12.9M in Q4 2025.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Artisan Partners's 13F filing for Q2 2026, filed 13 Aug 2026.